BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1781916)

  • 1. Disposition of alprazolam in human volunteers. Differences between genders.
    Kristjánsson F; Thorsteinsson SB
    Acta Pharm Nord; 1991; 3(4):249-50. PubMed ID: 1781916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of male-female differences in disposition and esterase hydrolysis of ramipril to ramiprilat in healthy volunteers after a single oral dose.
    Vree TB; Dammers E; Ulc I; Horkovics-Kovats S; Ryska M; Merkx ; Ijsbrand
    ScientificWorldJournal; 2003 Dec; 3():1332-43. PubMed ID: 14755115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alprazolam kinetics following sublingual and oral administration.
    Scavone JM; Greenblatt DJ; Shader RI
    J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
    Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.
    Smith RB; Gwilt PR; Wright CE
    Clin Pharm; 1983; 2(2):139-43. PubMed ID: 6883942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers.
    Glue P; Fang A; Gandelman K; Klee B
    Am J Ther; 2006; 13(5):418-22. PubMed ID: 16988537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of venlafaxine on the pharmacokinetics of alprazolam.
    Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
    Psychopharmacol Bull; 1998; 34(2):211-9. PubMed ID: 9641003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sertindole in healthy young and elderly male and female subjects.
    Wong SL; Cao G; Mack RJ; Granneman GR
    Clin Pharmacol Ther; 1997 Aug; 62(2):157-64. PubMed ID: 9284851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender related pharmacokinetics of diltiazem in healthy subjects.
    Sáenz-Campos D; Bayés MC; Martin S; Barbanoj MJ; Jané F
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):397-400. PubMed ID: 7582396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Zhou S; Kestell P; Tingle MD; Paxton JW
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gender and phase of the menstrual cycle on the kinetics of ranitidine in healthy volunteers.
    Flores Pérez J; Juárez Olguín H; Flores Pérez C; Pérez Guillé G; Guillé Pérez A; Camacho Vieyra A; Toledo López A; Carrasco Portugal M; Lares Asseff I
    Chronobiol Int; 2003 May; 20(3):485-94. PubMed ID: 12868543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired elimination of caffeine by oral contraceptive steroids.
    Patwardhan RV; Desmond PV; Johnson RF; Schenker S
    J Lab Clin Med; 1980 Apr; 95(4):603-8. PubMed ID: 7359014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pharmacokinetics of NS-105, a novel agent for cerebrovascular disease, in elderly and young subjects.
    Kumagai Y; Yokota S; Isawa S; Murasaki M; Mukai H; Miyatake S
    Int J Clin Pharmacol Res; 1999; 19(1):1-8. PubMed ID: 10450537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers.
    Barbanoj MJ; Urbano G; Antonijoan R; Ballester MR; Valle M
    Neuropsychobiology; 2007; 55(3-4):203-12. PubMed ID: 17878744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
    Masica AL; Mayo G; Wilkinson GR
    Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.
    Dadashzadeh S; Javadian B; Sadeghian S
    Biopharm Drug Dispos; 2006 Oct; 27(7):329-34. PubMed ID: 16892180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects.
    Bertz RJ; Kroboth PD; Kroboth FJ; Reynolds IJ; Salek F; Wright CE; Smith RB
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1317-29. PubMed ID: 9190868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S; Chompootaweep S; Thaworn N
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.